Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
TipRanks on MSN

Recursion Pharmaceuticals call volume above normal and directionally bullish

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 35,100 calls trading, 5x expected, and implied vol increasing almost 42 ...
IEEE

Modified Sigmoid Function-Based Proportionate Diffusion Recursive Adaptive Filtering Algorithm Over Sensor Network

Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...
Zacks Investment Research on MSN

Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $6.36, demonstrating a -6.33% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.63%.

Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event

Recursion Pharmaceuticals extended its winning streak to a third straight day on Wednesday, jumping 15.28 percent to close at ...

Is Recursion Pharmaceuticals a Millionaire Maker?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Blockonomi

Recursion Pharmaceuticals (RXRX) Stock Soars as AI Drug Discovery Hype Returns

Recursion Pharmaceuticals RXRX stock surged 16% in early October 2025 on renewed AI interest despite posting $171.9 million ...
eLife

A recursive pathway for isoleucine biosynthesis arises from enzyme promiscuity

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...